8–9 JuneBasel, Switzerland


Host Sponsor



...to Biotech Outsourcing Strategies Basel 2022

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

Since 2016 we are pleased to call Basel our home of our summer event. Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

Covid Policy: click here to read the latest on Covid guidelines.

Badge QR Code: A QR code will be sent to you on Thursday 4th June and a reminder email sent with the same QR Code on Tuesday 7th June. Please have this QR code ready to present when you arrive at the venue so that your badge can be printed without delay. Contact Bio2Business if you have not received your badge given the schedule outlined herein.

Book your accommodation at BOS Basel 2022 by clicking here.

View Exhibition Floor plan

Important checklist for Sponsors

Important checklist for Exhibition Sponsors

Follow us on LinkedIn to see our latest announcements

Featured Speaker (BOS Basel 2022)

photo of Dr Yogeshwar Bachhav

Hurdles to Develop a Parenteral Nanosuspension Formulation for Early Clinical Phase

Dr Yogeshwar Bachhav, Associate Director, AiCuris Anti-infective Cures AG

ABSTRACT: Click here to Read More

Featured Company (BOS Basel 2022)

Logo for ICROM SRL
ICROM srl is an Italian CDMO dedicated to the development and the GMP manufacture of Active Ingredients and Intermediates for pharmaceutical use on a small, medium and large scale.
ICROM holds segregated GMP units for the development and manufacture of high-potent APIs mainly for oncological application,...
View profile